Search

Your search keyword '"Bajolle, Fanny"' showing total 268 results

Search Constraints

Start Over You searched for: Author "Bajolle, Fanny" Remove constraint Author: "Bajolle, Fanny" Search Limiters Available in Library Collection Remove constraint Search Limiters: Available in Library Collection
268 results on '"Bajolle, Fanny"'

Search Results

1. Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection

4. Safety and efficacy of rivaroxaban in pediatric cerebral venous thrombosis (EINSTEIN-Jr CVT): for the EINSTEIN-Jr Cerebral Venous Thrombosis trial investigators

6. Safety and efficacy of anticoagulant therapy in pediatric catheter-related venous thrombosis (EINSTEIN-Jr CVC-VTE)

7. Position paper concerning the competence, performance and environment required for the practice of ablation in children and in congenital heart disease

8. Rivaroxaban for treatment of pediatric venous thromboembolism. An Einstein‐Jr phase 3 dose‐exposure‐response evaluation

9. Impact of Sophrology on cardiopulmonary fitness in teenagers and young adults with a congenital heart disease: The SOPHROCARE study rationale, design and methods

10. Common Genetic Variants Contribute to Risk of Transposition of the Great Arteries

15. Acute Heart Failure in Multisystem Inflammatory Syndrome in Children in the Context of Global SARS-CoV-2 Pandemic

16. Multisystem inflammatory syndrome in children during the COVID-19 waves: data from the Juvenile Inflammatory Rheumatism cohort

17. Inborn errors of OAS-RNase L in SARS-CoV-2-related multisystem inflammatory syndrome in children

20. Inborn errors of OAS–RNase L in SARS-CoV-2–related multisystem inflammatory syndrome in children

21. Additional file 1 of Expanding the phenome and variome of the ROBO-SLIT pathway in congenital heart defects: toward improving the genetic testing yield of CHD

22. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

23. Correction to “Hyper inflammatory syndrome following COVID-19 mRNA vaccine in children: A national post-authorization pharmacovigilance study”

24. Hyper inflammatory syndrome following COVID-19 mRNA vaccine in children: A national post-authorization pharmacovigilance study

26. Biallelic alterations in PLXND1 cause common arterial trunk and other cardiac malformations in humans

27. PPA2-associated sudden cardiac death: extending the clinical and allelic spectrum in 20 new families

28. The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodies

30. PPA2-associated sudden cardiac death: extending the clinical and allelic spectrum in 20 new families

31. Biallelic alterations in PLXND1 cause common arterial trunk and other cardiac malformations in humans.

32. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

33. X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19

34. Cohort profile: the ESC EURObservational Research Programme Atrial Fibrillation III (AF III) Registry

35. SARS-CoV-2-related MIS-C:A key to the viral and genetic causes of Kawasaki disease?

40. Acute heart failure in multisystem inflammatory syndrome in children (MIS-C) in the context of global SARS-CoV-2 pandemi

46. Common Genetic Variants Contribute to Risk of Transposition of the Great Arteries

47. CYP2C9, VKORC1, and CYP4F2 polymorphisms and pediatric warfarin maintenance dose : a systematic review and meta-analysis

48. Safety and efficacy of rivaroxaban in pediatric cerebral venous thrombosis (EINSTEIN-Jr CVT).

49. Association between SARS-CoV-2 infection and Kawasaki-like multisystem inflammatory syndrome: a retrospective matched case–control study, Paris, France, April to May 2020

Catalog

Books, media, physical & digital resources